Eitan Group Rebrands as Eitan Medical

NETANYA, Israel, November 16, 2020 – Eitan Medical announced today that, as of November 16, 2020, it has rebranded, consolidating its product lines under the new Eitan Medical brand. Eitan Medical is a global leader in advanced infusion therapy solutions across the care continuum. More>>

New IATA Guidance Prepares for Global Vaccine Distribution

The International Air Transport Association (IATA) released guidance to ensure that the air cargo industry is ready to support the large-scale handling, transport and distribution of a COVID-19 vaccine. IATA’s Guidance for Vaccine and Pharmaceutical Logistics and Distribution provides recommendations for governments and the logistics supply chain in preparation for what will be the largest and most complex global logistics operation ever undertaken. More>>

Roquette’s Innovative Plant-Based Solution Unlocks Possibilities for Veggie Softgel Market

Market-first plant-based softgel system provides a strong alternative to gelatin for nutraceutical and pharmaceutical manufacturers and marketers of softgel products More>>

bioMérieux announces the expansion of the CE marking of its molecular biology ARGENE® SARS-CoV-2 diagnostic test to include saliva specimens.

Marcy l’Etoile, France – November 16, 2020 – bioMérieux, a world leader in the field of in vitro diagnostics, has announced the expansion of its ARGENE® range for the detection of SARS-CoV-2. As a complement to nasopharyngeal swab specimens, the singleplex SARS-CoV-2 R-GENE® real-time PCR test may now be used on saliva and oropharyngeal (throat) swab specimens for the detection of the virus that causes COVID-19. This development helps optimize laboratory workflows. More>>

ESGE Medtronic Artificial Intelligence Research Award could help prevent almost 100,000 more colorectal cancers across Europe

The European Society of Gastrointestinal Endoscopy (ESGE) and Medtronic has collaborated to create the AI Research Award to support application of AI in the field of colonoscopy. Medtronic will support this Research Award through provision of 75 GI Genius™ platforms to the award winning research projects. The total investment from Medtronic, including both the value of the technology loan, research and training for AI exceeds €1.5million More>>

Data Showing SARS-CoV-2 Reactive T Cells are Associated with Protection from COVID-19 – and Can Be Both Detected and Measured Using Oxford Immunotec’s T-SPOT® Technology – is Published by Public Health England and Oxford Immunotec

Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announced the release of data from a prospective cohort study in keyworkers in the UK – a collaboration between the Company and Public Health England (PHE). The data demonstrates that SARS-CoV-2 reactive T cells may be sufficient to give protection from COVID-19 and that serology alone may underestimate those at lower risk of clinical SARS-CoV-2 infection. More>>

Save The Date: Bormioli Pharma Envision Press Conference

Bormioli Pharma Envision is a milestone, the first digital event for the company. As part of this important moment, Bormioli Pharma has decided to dedicate a unique presentation to the press. The conference, in virtual mode and by invitation only, will give you the opportunity to learn about the company’s strategies for the future. Andrea Lodetti, CEO of Bormioli Pharma and Andrea Sentimenti, Marketing & Innovation Director, will present a preview of the new organization of the company’s product range, involving participants in the company’s innovation process. Bormioli Pharma’s top management will also show the latest products and new prototypes. More>>

Johnson & Johnson Initiates Second Global Phase 3 Clinical Trial of its Janssen COVID-19 Vaccine Candidate

The Phase 3 ENSEMBLE study (NCT04505722) of the single-dose regimen of JNJ-78436735, the investigational vaccine candidate for the prevention of COVID-19 being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, continues to enrol and vaccinate study participants. ENSEMBLE is proceeding to enrol up to 60,000 participants worldwide.1 More>>

Antares Vision Strengthens Traceability Position by Acquiring Assets of Adents

The Italian multinational company will expand its portfolio of software solutions and cloud services for end-to-end traceability, increasing its international presence in Europe and the USA More>>

Bachem is now expanding into Oligonucleotides

An interview with Torsten Wöhr, Head of Oligonucleotides at Bachem AG in Switzerland

The global market for oligonucleotide therapeutics is expanding rapidly. What is Bachem’s strategy in entering this competitive environment? Dr. Torsten Wöhr*: I think it is important for our customers to understand that the decision by Bachem leadership to enter the field of oligonucleotide manufacturing was well-prepared and ultimately taken in line with the company’s long-term growth plan. We are operative since 2019 and are gradually expanding our expert resource pool, capabilities and capacity for oligonucleotides. More>>